On the other side, metformin has been reported to have chemopreventive potential against CRC, mainly by its effects on AMP-kinase activity and subsequent inhibition of IGF-1 and mTOR signaling pathways [197]. This evidence concerns the gene IGF1 and colorectal carcinoma.